Cambau, Emmanuelle <br/><br/>
Performance and economic evaluation of the molecular detection of pathogens for patients with severe infections: the EVAMICA open-label, cluster-randomised, interventional crossover trial.  [electronic resource] 

 -  Intensive care medicine  Nov 2017 
 - 1613-1625 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1432-1238 
<br/><br/><label>Standard No.: </label>10.1007/s00134-017-4766-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Anti-Bacterial Agents--therapeutic use<br/>Cost-Benefit Analysis<br/>Cross-Over Studies<br/>Endocarditis--blood<br/>Febrile Neutropenia--blood<br/>Female<br/>Hospital Mortality<br/>Humans<br/>Intensive Care Units--statistics & numerical data<br/>Intention to Treat Analysis<br/>Male<br/>Middle Aged<br/>Molecular Diagnostic Techniques--economics<br/>Quality Improvement<br/>Retrospective Studies<br/>Risk Factors<br/>Sepsis--blood<br/>Time Factors<br/>Time-to-Treatment--economics